Amgen Inc (NASDAQ:AMGN)
| 207.74 BATS BZX Real-Time Price As of Oct 15 |  0.00 / 0.00%Today’s Change | 200.47 Today|||52-Week Range 276.69 | -9.65% Year-to-Date |
Latest AMGN News | Press Releases
Today’s Trading
| Previous close | 207.74 |
| Today’s open | 208.49 |
| Day’s range | 206.25 - 209.02 |
| Volume | 145,953 |
| Average volume (3 months) | 2,494,610 |
| Market cap | $118.0B |
Data as of 4:00pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | -4.37% |
| Earnings growth (this year) | -1.36% |
| Earnings growth (next 5 years) | +6.14% |
| Revenue growth (last year) | +8.53% |
| P/E ratio | 21.1 |
| Price/Sales | 5.37 |
| Price/Book | 12.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNAModerna Inc | 0.00 | 0.00% |
| GILDGilead Sciences | 0.00 | 0.00% |
| ILMNIllumina Inc | 0.00 | 0.00% |
| BIIBBiogen | 0.00 | 0.00% |
Data as of 5:53pm ET, 10/15/2021
Financials
| Next reporting date | November 2, 2021 |
| EPS forecast (this quarter) | $4.26 |
| Annual revenue (last year) | $25.2B |
| Annual profit (last year) | $7.3B |
| Net profit margin | 28.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
